ANTICUERPOS ANTI-MPO
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BIO SIMEX, S.A. DE C.V.·Registered August 16, 2019REACTIVOS PARA LA DETERMINACIÓN CUALITATIVA Y CUANTITATIVA DE ANTICUERPOS ANTI-MPO EN SUERO O PLASMA HUMANO. AGENTES DE DIAGNÓSTICO IN VITRO Y PARA USO EXCLUSIVO EN LABORATORIO CLÍNICO O DE GABINETES.
REAGENTS FOR THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF ANTI-MPO ANTIBODIES IN HUMAN SERUM OR PLASMA. IN VITRO DIAGNOSTIC AGENTS AND FOR EXCLUSIVE USE IN CLINICAL LABORATORY OR CABINETS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOS PARA LA DETERMINACIÓN DE ANTICUERPOS ANTI-MIELOPEROXIDASA (ANTI-MPO)
- Trade Name (English)
- REAGENTS FOR THE DETERMINATION OF ANTI-MYELOPEROXIDASE ANTIBODIES (ANTI-MPO)
- Analysis ID
- 1647R2019 SSA
- Registration Date
- August 16, 2019
- Name (Spanish)
- BIO SIMEX, S.A. DE C.V.
- Name (English)
- BIO SIMEX, S.A. DE C.V.
Access comprehensive regulatory information for ANTICUERPOS ANTI-MPO (ANTI-MPO ANTIBODIES) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1647R2019 SSA and manufactured by BIO SIMEX, S.A. DE C.V.. The device was registered on August 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.